Grifols enters distribution agreement to market normal saline solution, minimize shortage in US

Grifols, a producer of plasma-derived medicines, entered a distribution agreement with Henry Schein, which will market and distribute Grifol's 500 milliliter normal saline solution in the U.S.

Grifols currently manufactures the solution in Murcia, Spain. In 2017, Grifols received FDA approval to market its normal saline solution in 500 milliliter polypropylene bags in the U.S. to mitigate the current shortage of normal saline in the U.S.

This agreement represents a step to further develop Grifols' hospital division in the U.S., a key market for the division growth strategy.

More articles on supply chain:

4 things to know about BostonSight's new CMO Dr. Daniel Brooks

Medial EarlySign secures $30M in series B funding — 3 insights

Takeda constructing modular cell therapy facility in Dublin

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers